Phase Ib study of dulanermin combined with FOLFIRI (with or without bevacizumab [BV]) in previously treated patients (Pts) with metastatic colorectal cancer (mCRC)

被引：0

作者：

Kasubhai, Saifuddin M.

Bendell, Johanna C.

Kozloff, Mark

Kapp, Amy V.

Ashkenazi, Avi

Royer-Joo, Stephanie

Portera, Chia C.

机构：

[1] Northwest Med Specialties, Tacoma, WA USA

[2] Sarah Cannon Res Inst, Nashville, TN USA

[3] Ingalls Hosp, Harvey, IL USA

[4] Univ Chicago, Harvey, IL USA

[5] Genentech Inc, San Francisco, CA 94080 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3543

引用

页数：1